Spyre Therapeutics (SYRE) DMA 200 (2017 - 2026)
Spyre Therapeutics (SYRE) DMA 200 (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
DMA 200 |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
3.89 |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
136.77 |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
8.11 |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
25.76 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
16.36 |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
4.45 |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
9.62 |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
438.42 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
110.64 |
| 10 |
Spyre Therapeutics |
6.35 Bn |
6.35 Bn |
- |
39.52 |
| Date | Value |
|---|
| Jun 12, 2026 |
39.52 |
| Jun 11, 2026 |
39.20 |
| Jun 10, 2026 |
38.88 |
| Jun 9, 2026 |
38.59 |
| Jun 8, 2026 |
38.28 |
| Jun 5, 2026 |
38.01 |
| Jun 4, 2026 |
37.72 |
| Jun 3, 2026 |
37.41 |
| Jun 2, 2026 |
37.13 |
| Jun 1, 2026 |
36.87 |
| May 29, 2026 |
36.60 |
| May 28, 2026 |
36.31 |
| May 27, 2026 |
36.03 |
| May 26, 2026 |
35.74 |
| May 22, 2026 |
35.45 |
| May 21, 2026 |
35.16 |
| May 20, 2026 |
34.87 |
| May 19, 2026 |
34.59 |
| May 18, 2026 |
34.34 |
| May 15, 2026 |
34.07 |
